Showing results (61-70 of 93) with videos related to
Sort By:
Pageof 10
Journal for Immunotherapy of Cancer|May 9, 2025
Carboplatin, etoposide, atezolizumab, and bevacizumab in the first-line treatment of patients with extensive stage small-cell lung cancer: the GOIRC-01-2019 CeLEBrATE studyGiuseppe Lamberti, Karim Rihawi, Francesca Mazzoni, et al.Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|April 9, 2022
Development of a prognostic model of overall survival in oropharyngeal cancer from real-world data: PRO.M.E.THE.OFrancesco Miccichè, Giuditta Chiloiro, Silvia Longo, et al.Current Oncology (Toronto, Ont.)|November 26, 2024
Current Radiotherapy Management of Extensive-Stage Small-Cell Lung Cancer in the Immunotherapy Era: An Italian National Survey on Behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Alessio Bruni, Vieri Scotti, Maria Alessia Zerella, et al.Critical Reviews in Oncology/Hematology|May 8, 2023
A systematic review and meta-analysis on the optimal treatment duration of checkpoint inhibitoRS in solid tumors: The OTHERS studyGiorgio Bogani, Michela Cinquini, Diego Signorelli, et al.Life (Basel, Switzerland)|August 26, 2022
Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian CentresPaolo Cameli, Paola Faverio, Katia Ferrari, et al.Endocrine|July 7, 2021
Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experienceCamilla Bardasi, Andrea Spallanzani, Stefania Benatti, et al.Journal of Neuro-Oncology|March 5, 2016
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective studyEnrico Franceschi, Roberta Depenni, Alexandro Paccapelo, et al.Journal of Neuro-Oncology|November 11, 2017
Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective studyEnrico Franceschi, Roberta Depenni, Alexandro Paccapelo, et al.Head & Neck|March 4, 2025
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian CentersFrancesca Caspani, Stefano Cavalieri, Ester Orlandi, et al.The Oncologist|June 8, 2021
Dexamethasone-Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High-Dose Cisplatin: A Randomized Noninferiority StudyLuigi Celio, Diego Cortinovis, Alessio Aligi Cogoni, et al.Pageof 10